2016 ALS Research Highlights

The research investments made in 2016 will fund 20 projects across the country, enabling 31 researchers at eight academic institutions to engage in important ALS research. These include:

  • With co-funding from Brain Canada (with financial support from Health Canada), two large-scale multi-year team initiatives – one of which is using stem cell technology to better understand and potentially treat ALS, while the other is studying in a new way the gene most commonly linked to ALS development.
  • $1.5 million awarded to early-career researchers through three different grant programs that invest in the future of ALS research by developing the next generation of scientists and enabling them to focus their work on ALS.
  • $700,000 to seven smaller studies, co-funded with Brain Canada (with financial support from Health Canada) that enable investigators to explore outside-of-the-box research.
  • The first recipients of the ALS Canada Clinical Management Grant. This program funds research focused on avenues to maximize function, minimize disability and optimize quality of life through symptom management and support to families and persons living with ALS. The funding allowed a group of researchers to explore the use of cannabinoids, substances that have demonstrated therapeutic effects including anti-inflammatory, analgesic, and anti-anxiety, for ALS symptom management.